4.7 Article

Development of novel bisubstrate-type inhibitors of histone methyltransferase SET7/9

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 18, Issue 23, Pages 8158-8166

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2010.10.022

Keywords

Histone methyltransferase; Small molecule inhibitor; Bisubstrate inhibitor; Epigenetics; SET7/9

Funding

  1. Ministry of Education, Science, Sports and Culture, Japan [19201044, 19790090, 22790106]
  2. Mochida Memorial Foundation
  3. Astellas Foundation
  4. Grants-in-Aid for Scientific Research [22790106, 19201044, 19790090] Funding Source: KAKEN

Ask authors/readers for more resources

Histone modification, for example, by histone deacetylase (HDAC) and histone lysine methyltransferase (HMT), plays an important role in regulating gene expression. To obtain novel inhibitors as tools for investigating the physiological function of members of the HMT family, we designed and synthesized novel inhibitors, which are amine analogues of adenosylmethionine (AdoMet; the cofactor utilized in the methylation reaction) bearing various alkylamino groups coupled via an ethylene linker. The inhibitory activities of these compounds towards SET7/9, an HMT, were evaluated. It was found that introduction of an alkylamino group increased the inhibitory activity. (C) 2010 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available